Literature DB >> 10075723

Antisense oligonucleotides containing modified bases inhibit in vitro translation of Leishmania amazonensis mRNAs by invading the mini-exon hairpin.

D Compagno1, J N Lampe, C Bourget, I V Kutyavin, L Yurchenko, E A Lukhtanov, V V Gorn, H B Gamper, J J Toulmé.   

Abstract

Complementary oligodeoxynucleotides (ODNs) that contain 2-aminoadenine and 2-thiothymine interact weakly with each other but form stable hybrids with unmodified complements. These selectively binding complementary (SBC) agents can invade duplex DNA and hybridize to each strand (Kutyavin, I. V., Rhinehart, R. L., Lukhtanov, E. A., Gorn, V. V., Meyer, R. B., and Gamper, H. B. (1996) Biochemistry 35, 11170-11176). Antisense ODNs with similar properties should be less encumbered by RNA secondary structure. Here we show that SBC ODNs strand invade a hairpin in the mini-exon RNA of Leishmania amazonensis and that the resulting heteroduplexes are substrates for Escherichia coli RNase H. SBC ODNs either with phosphodiester or phosphorothioate backbones form more stable hybrids with RNA than normal base (NB) ODNs. Optimal binding was observed when the entire hairpin sequence was targeted. Translation of L. amazonensis mRNA in a cell-free extract was more efficiently inhibited by SBC ODNs complementary to the mini-exon hairpin than by the corresponding NB ODNs. Nonspecific protein binding in the cell-free extract by phosphorothioate SBC ODNs rendered them ineffective as antisense agents in vitro. SBC phosphorothioate ODNs displayed a modest but significant improvement of leishmanicidal properties compared with NB phosphorothioate ODNs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10075723     DOI: 10.1074/jbc.274.12.8191

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Knockdown of LdMC1 and Hsp70 by antisense oligonucleotides causes cell-cycle defects and programmed cell death in Leishmania donovani.

Authors:  Puneet Raina; Sukhbir Kaur
Journal:  Mol Cell Biochem       Date:  2011-07-31       Impact factor: 3.396

2.  Increased efficacy of antileishmanial antisense phosphorothioate oligonucleotides in Leishmania amazonensis overexpressing ribonuclease H.

Authors:  M Mishra; J R Bennett; G Chaudhuri
Journal:  Biochem Pharmacol       Date:  2001-02-15       Impact factor: 5.858

3.  Enhanced activity of antisense phosphorothioate oligos against leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions.

Authors:  M Mishra; J M Porter-Kelley; P K Singh; J R Bennett; G Chaudhuri
Journal:  Biochem Pharmacol       Date:  2001-09-01       Impact factor: 5.858

Review 4.  Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications.

Authors:  Wenzhang Cha; Rengen Fan; Yufeng Miao; Yong Zhou; Chenglin Qin; Xiangxiang Shan; Xinqiang Wan; Jinbo Li
Journal:  Molecules       Date:  2017-05-11       Impact factor: 4.411

Review 5.  The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides.

Authors:  Miklós Bege; Anikó Borbás
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-22

6.  Gene regulation of pteridine reductase 1 in leishmania promastigotes and amastigotes using a full-length antisense construct.

Authors:  F Kheirandish; M Bandehpour; N Davoudi; N Mosaffa; S Dawood; B Kazemi; A Haghighi; A Khamesipour; H Masjedi; M Mohebali; F Mahboudi
Journal:  Iran J Parasitol       Date:  2013-04       Impact factor: 1.012

7.  Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance.

Authors:  Olga Patutina; Daria Chiglintseva; Elena Bichenkova; Svetlana Gaponova; Nadezhda Mironova; Valentin Vlassov; Marina Zenkova
Journal:  Molecules       Date:  2020-05-25       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.